Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03567239 · ClinicalTrials.gov registry record · NA

Impact of Custom Assistive and Adaptive Technology in Rehabilitation

A NA study of Stroke and Multiple Sclerosis, sponsored by Madonna Rehabilitation Hospital.

Completed
Registry status
NA
Development phase
5
Enrollment target
1
Study location

NCT03567239 is a NA study of Stroke and Multiple Sclerosis that has completed, run by Madonna Rehabilitation Hospital. The registered enrollment target is 5 participants, below the 12,016-participant average among 454 other Stroke trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03567239, a NA study of Stroke and Multiple Sclerosis, has completed, sponsored by Madonna Rehabilitation Hospital.

COMPLETED
Registry status
NA
Development phase
5 participants
Enrollment target
1
Study location

Study Summary

Madonna's Rehabilitation Engineering Center of Excellence (REC) is continually developing custom devices for persons with disabilities. These devices are created to improve the independence of individuals living with disabilities at Madonna Rehabilitation Hospitals and in the community. The purpose of this study is to investigate the impact custom assistive and adaptive devices have on patient independence, quality of life, and experience at Madonna Rehabilitation Hospitals.

Interventions

  • DEVICE Using adaptive device.

Study Locations (1)

Nebraska

  • Madonna Rehabilitation Hospitals - Lincoln

Trial Details

FieldValue
Enrollment Target 5 participants
Start Date 2018-06-25
Est. Completion 2020-02-26
Phase NA

Sponsor

Madonna Rehabilitation Hospital

1 total trials

What the Registry Record Tells You About NCT03567239

The ClinicalTrials.gov registry entry for NCT03567239 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 5 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 12,016-participant average among 454 other Stroke trials with a reported enrollment target (100% lower). The listed sponsor is Madonna Rehabilitation Hospital, which has 1 total studies on file at ClinicalTrials.gov.

The record links to 6 conditions, with Stroke appearing as the primary indexed condition, and to 1 intervention - of which Using adaptive device. is the first listed.

NCT03567239 reports 1 study location spanning 1 distinct geographic area - top geographies include Nebraska.

Frequently Asked Questions

What is clinical trial NCT03567239 about?

NCT03567239 is a clinical study titled "Impact of Custom Assistive and Adaptive Technology in Rehabilitation". Madonna's Rehabilitation Engineering Center of Excellence (REC) is continually developing custom devices for persons with disabilities. These devices are created to improve the independence of individuals living with disabilities at Madonna Rehabilitation Hospitals and in the community. The purpose ...

What is the current status of trial NCT03567239?

This trial is currently completed. It is a NA study. The enrollment target is 5 participants. The study started on 2018-06-25. Estimated completion is 2020-02-26.

What conditions does trial NCT03567239 study?

This clinical trial studies the following conditions: Stroke, Multiple Sclerosis, Spinal Cord Injuries, Brain Injuries, Disability Physical.

What interventions are being tested in trial NCT03567239?

The interventions under investigation include: Using adaptive device. (DEVICE).

Who is sponsoring clinical trial NCT03567239?

This trial is sponsored by Madonna Rehabilitation Hospital, which has 1 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03567239 being conducted?

This trial has 1 study location across Nebraska. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Stroke

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.